SAN JOSE, Calif.--(BUSINESS WIRE)--DFine, Inc., developer of minimally invasive solutions for treating vertebral pathologies, announced today the appointment of Lewis Yee to the position of Chief Financial Officer. Lewis brings over 25 years of finance and operations experience across multiple industry sectors. Prior to joining DFine, Lewis was the head of finance at Nobel Biocare Holdings USA, Inc. for 9 years with full responsibility for accounting, controlling, treasury and tax management for their North American region. During this time, Lewis was instrumental in building controls and the financial planning and analysis systems needed to propel Noble Biocare to a US market leading position with record years of profitability.
